Cargando…
The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy
Cancer immunotherapy shows durable treatment responses and therapeutic benefits compared to other cancer treatment modalities, but many cancer patients display primary and acquired resistance to immunotherapeutics. Immunosuppressive tumor microenvironment (TME) is a major barrier to cancer immunothe...
Autores principales: | Akter, Zakia, Salamat, Narges, Ali, Md. Yousuf, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851275/ https://www.ncbi.nlm.nih.gov/pubmed/36686754 http://dx.doi.org/10.3389/fonc.2022.1072739 |
Ejemplares similares
-
Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023) -
Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
por: Cai, Huazhong, et al.
Publicado: (2023) -
Targeting T Cell Immunometabolism for Cancer Immunotherapy; Understanding the Impact of the Tumor Microenvironment
por: Mockler, Mary B., et al.
Publicado: (2014) -
Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023) -
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
por: Welters, Marij J. P., et al.
Publicado: (2020)